iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Large Volume Increase – Should You Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw strong trading volume on Friday. Approximately 498,149 shares were traded during trading, an increase of 217% from the previous session’s volume of 157,136 shares. The stock last traded at $98.4180 and had previously closed at $99.00.

iShares U.S. Pharmaceuticals ETF Stock Performance

The company has a market capitalization of $1.60 billion, a PE ratio of 17.75 and a beta of 0.49. The company’s fifty day moving average is $103.16 and its 200-day moving average is $95.57.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of IHE. Hudock Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 3.9% during the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after acquiring an additional 114 shares during the period. Sunbelt Securities Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 14.3% during the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock valued at $83,000 after buying an additional 120 shares in the last quarter. Root Financial Partners LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 36.5% in the 1st quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after buying an additional 186 shares during the period. Corient Private Wealth LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 3.1% in the 4th quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock worth $552,000 after acquiring an additional 198 shares in the last quarter. Finally, Cornerstone Wealth Group LLC increased its position in shares of iShares U.S. Pharmaceuticals ETF by 13.7% during the first quarter. Cornerstone Wealth Group LLC now owns 2,847 shares of the company’s stock worth $246,000 after acquiring an additional 342 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.